Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

Hospital admissions and mortality from the Coronavirus disease 2019 (COVID-19) pandemic are spreading throughout the world, and second and third waves are thought to be likely. Risk factors for severe COVID-19 include diabetes, chronic kidney disease and cardiovascular disease. Currently, there is n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med
Asıl Yazarlar: Fernandez-Fernandez, Beatriz, D’Marco, Luis, Górriz, Jose Luis, Jacobs-Cachá, Conxita, Kanbay, Mehmet, Luis-Lima, Sergio, Porrini, Esteban, Sarafidis, Pantelis, Soler, María José, Ortiz, Alberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409231/
https://ncbi.nlm.nih.gov/pubmed/32605278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072030
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller